These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 27282449)
1. Prognostic value of post-treatment metabolic tumor volume from Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449 [TBL] [Abstract][Full Text] [Related]
2. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma. Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921 [TBL] [Abstract][Full Text] [Related]
3. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake. Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients. Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010 [TBL] [Abstract][Full Text] [Related]
5. Optimization of scan initiation timing after Nakajima R; Abe K; Momose M; Fukushima K; Matsuo Y; Kimura K; Kondo C; Sakai S Ann Nucl Med; 2017 Feb; 31(2):190-197. PubMed ID: 27885545 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas. Zhao F; Cui Y; Li M; Fu Z; Chen Z; Kong L; Yang G; Yu J Nucl Med Biol; 2014 Sep; 41(8):710-5. PubMed ID: 24929963 [TBL] [Abstract][Full Text] [Related]
7. Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected Jung TY; Kim IY; Lim SH; Park KS; Kim DY; Jung S; Moon KS; Jang WY; Kang SR; Cho SG; Min JJ; Bom HS; Kwon SY EJNMMI Res; 2017 Dec; 7(1):45. PubMed ID: 28536967 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [TBL] [Abstract][Full Text] [Related]
9. The roles of Kim S; Kim D; Kim SH; Park MA; Chang JH; Yun M Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1012-1020. PubMed ID: 29511838 [TBL] [Abstract][Full Text] [Related]
10. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors. Tripathi M; Sharma R; Varshney R; Jaimini A; Jain J; Souza MM; Bal J; Pandey S; Kumar N; Mishra AK; Mondal A Clin Nucl Med; 2012 Feb; 37(2):158-63. PubMed ID: 22228339 [TBL] [Abstract][Full Text] [Related]
11. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028 [TBL] [Abstract][Full Text] [Related]
12. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer. Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564 [TBL] [Abstract][Full Text] [Related]
16. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis. Son SH; Lee SW; Jeong SY; Song BI; Chae YS; Ahn BC; Lee J AJR Am J Roentgenol; 2015 Oct; 205(4):878-85. PubMed ID: 26204115 [TBL] [Abstract][Full Text] [Related]
17. Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma. Chiba Y; Kinoshita M; Okita Y; Tsuboi A; Isohashi K; Kagawa N; Fujimoto Y; Oji Y; Oka Y; Shimosegawa E; Morita S; Hatazawa J; Sugiyama H; Hashimoto N; Yoshimine T J Neurosurg; 2012 Apr; 116(4):835-42. PubMed ID: 22242671 [TBL] [Abstract][Full Text] [Related]
18. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366 [TBL] [Abstract][Full Text] [Related]
19. Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma. Kamson DO; Mittal S; Robinette NL; Muzik O; Kupsky WJ; Barger GR; Juhász C Neuro Oncol; 2014 Oct; 16(10):1373-83. PubMed ID: 24670609 [TBL] [Abstract][Full Text] [Related]
20. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes. Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]